Demet ÖZKARAMANLI GÜR, Ozcan GÜR, Selami GÜRKAN

The comparative effects of esmolol and amiodarone on isolated coronary artery bypass grafts

Background/aim: Esmolol and amiodarone are two most commonly used antiarrhythmic drugs in coronary artery bypass grafting (CABG) surgery. Nevertheless, blockade of beta-2 receptors by increasing doses raise concerns about possible vasospasms. We studied the vasoactive effects of amiodarone and esmolol on left internal mammary artery (LIMA), radial artery (RA), and saphenous vein (SV) grafts. Materials and methods: After determining the presence of functional smooth muscle and endothelial layers, the responses of submaximally preconstricted graft samples were recorded in a tissue bath system. A total of 96 graft samples from 40 patients were used: 16 LIMA, 16 RA, and 16 SV grafts for each drug. Esmolol and amiodarone were added to reservoirs separately, starting from a concentration of 10-8 M until a concentration of 10-4 M. Results: Although both drugs caused vasodilatation, amiodarone exhibited a more potent vasodilatory effect than esmolol (P < 0.0001 for LIMA, P = 0.0128 for RA, and P < 0.0001 for SV). The vasodilatation rates with esmolol were 48.99 ± 2.28% in LIMA, 49.77 ± 3.03% in RA, and 41.90 ± 4.05% in SV grafts and with amiodarone they were 71.65 ± 5.18% in LIMA, 58.61 ± 5.87% in RA, and 65.07 ± 4.09% in SV grafts. Conclusion: This in vitro study revealed that even increasing doses of both drugs induce vasodilatation of CABG grafts, with amiodarone having a more potent vasodilatory effect than esmolol.

Keywords:

Amiodarone esmolol, coronary artery bypass grafts, tissue bath system,

PDF

___

Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001; 135: 1061-1073.
Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH, Mangano DT; Investigators of the Isch- emia Research and Education Foundation, Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004; 291: 1720-1729.
Omer S, Cornwell LD, Bakshi A, Rachlin E, Preventza O, Rosengart TK, Coselli JS, Lemaire SA, Petersen NJ, Pattakos G et al. Incidence, predictors, and impact of postoperative atrial fibrillation after coronary artery bypass grafting in military vet- erans. Tex Heart Inst J 2016; 43: 397-403.
Ferguson TB, Coombs LP, Peterson ED. Society of Thoracic Surgeons National Adult Cardiac Surgery Database. Preopera- tive beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA 2002; 287: 2221- 2227.
Bagshaw SM, Galbraith PD, Mitchell LB, Sauve R, Exner DV, Ghali WA. Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. Ann Thorac Surg 2006; 82: 1927-1937.
Mason JW. Amiodarone. N Eng J Med 1987; 316: 455-466.
Cheung M, Seres T, Cleveland J, Kounis NG. Kounis syndrome, a coronary hypersensitivity disorder: a rare case of amiodarone- induced coronary vasospasm and simultaneous peripheral va- sodilation intraoperatively. Int J Cardiol 2016; 218: 267-268.
Gur O, Ege T, Gurkan S, Ozkaramanli Gur D, Karadag H, Cakir H, Duran E. In vitro effects of lidocaine hydrochloride on coro- nary artery bypass grafts. J Cardio Vasc Surg (Torino) 2012; 53: 665-669.
Frakes MA. Esmolol: a unique drug with ED applications. J Emerg Nurs 2001; 27: 47-51.
Wolman RL, Fielder MA. Esmolol and beta-adrenergic block- ade. AANA J 1991; 59: 541-548.
Bignami E, Guarnieri M, Franco A, Gerli C, De Luca M, Mona- co F, Landoni G, Zangrillo A. Esmolol before cardioplegia and as cardioplegia adjuvant reduces cardiac troponin release after cardiac surgery. A randomized trial. Perfusion 2016; 1: 1-8.
Muller MD, Gao Z, Patel HM, Heffernan MJ, Leuenberger UA, Sinoway LI. β-Adrenergic blockade enhances coronary vaso- constrictor response to forehead cooling. Am J Physiol Heart Circ Physiol 2014; 306: 910-917.
Ross AJ, Gao Z, Pollock JP, Leuenberger UA, Sinoway LI, Muller MD. β-Adrenergic receptor blockade impairs coronary exercise hyperemia in young men but not older men. Am J Physiol Heart Circ Physiol 2014; 307: 1497-1503.
Toda N. Vasodilating β-adrenoceptorblockers as cardiovascu- lar therapeutics. Pharmacol Ther 2003; 100: 215– 234.
Arnalich-Montiel A, Gonzàlez MC, Delgado-Baeza E, Delga- do-Martos MJ, Condezo-Hoyos L, Martos-Rodríguez A, Ro- dríguez-Rodríguez P, Quintana-Villamandos B. Short-term es- molol improves coronary artery remodeling in spontaneously hypertensive rats through increased nitric oxide bioavailability and superoxide dismutase activity. Biomed Res Int 2014; 2014: 531087.
Chen SH, Hu ZY, Zhang JJ, Ye F, Kan, Xu T, Liu ZZ, Zhang JX, Chen M. Acute effects of nicardipine and esmolol on the cardiac cycle, intracardiac hemodynamic and endothelial shear stress in patients with unstable angina pectoris and moderate coronary stenosis: Results from single center, randomized study. Cardiovasc Ther 2012; 30:162-71.
Charlier R, Deltour G, Baudine A, Chaillet F. Pharmacology of amiodarone, and anti-anginal drug with a new biological pro- file. Arzneimittelforschung 1968; 18: 1408-1417.
Radhino R, Poli E, Pelà G, Gargano M, Manca C. Inhibitory actions of amiodarone on the isolated rabbit heart and aorta. Gen Pharmacol 1989; 20: 313-317.
Grossman M, Dobrev D, Kirch W. Amiodarone causes endo- thelium-dependent vasodilation in human hand veins in vivo. Clin Pharmacol Ther 1998; 64: 302-311.
Karaca OG, Ege T, Canbaz S, Gür Ö, Karadağ H, Ecevit AN, Kalender M. In vitro effects of amiodarone on coronary artery bypass grafts. Turk Gogus Kalp Dama 2015; 23: 14-18.
Gough WB, Zeiler RH, Barecca P, El-Sherif N. Hypotensive ac- tion of commercial intravenous amiodarone and polysorbate 80 in dogs. J Cardiovasc Pharmacol 1982; 4: 375-380.
Halici Z, Ozbakis D, Odabasoglu F, Suleyman H, Cadirci E, Halici M. Amiodarone has anti-inflammatory and anti-oxida- tive properties: an experimental study in rats with carrageen- an-induced paw edema. Eur J Pharmacol 2007; 566: 215-221.
He GW, Liu ZG. Comparison of nitric oxide release and endo- thelium-derived hyperpolarizing factor-mediated hyperpolarization between human radial and internal mammary arteries. Circulation 2001, 104: I344-1349.